|
Infinium Pharmachem Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
397.03 Cr.
|
P/BV
|
6.28
|
Book Value (Rs.)
|
45.40
|
|
52 Week High/Low (Rs.)
|
393/178
|
FV/ML
|
10/500
|
P/E(X)
|
35.13
|
|
Bookclosure
|
13/09/2023
|
EPS (Rs.)
|
8.12
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 135.64 | 114.22 | 99.12 | 70.53 | 38.84 |
| Total Operating Revenues | 135.64 | 114.22 | 99.12 | 70.53 | 38.84 |
| | | | | | |
| Other Income | 1.54 | 1.35 | 0.93 | 0.62 | 0.57 |
| Total Revenue | 137.18 | 115.58 | 100.05 | 71.15 | 39.42 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 98.83 | 71.53 | 54.22 | 41.98 | 28.30 |
| Purchase Of Stock-In Trade | 9.22 | 8.64 | 24.14 | 15.93 | 2.87 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -4.95 | 0.40 | -1.62 | -3.06 | -1.04 |
| Employee Benefit Expenses | 5.91 | 5.37 | 3.54 | 2.75 | 2.09 |
| Finance Costs | 2.19 | 3.10 | 1.70 | 1.16 | 1.24 |
| Depreciation And Amortisation Expenses | 2.67 | 1.34 | 0.63 | 0.65 | 0.58 |
| Other Expenses | 8.10 | 12.24 | 8.81 | 7.97 | 4.13 |
| Total Expenses | 121.97 | 102.62 | 91.42 | 67.38 | 38.18 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 15.21 | 12.95 | 8.63 | 3.77 | 1.24 |
| | | | | | |
| Profit/Loss Before Tax | 15.21 | 12.95 | 8.63 | 3.77 | 1.24 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 3.69 | 3.11 | 1.94 | 1.05 | 0.37 |
| Deferred Tax | 0.03 | 0.02 | -0.01 | -0.01 | 0.00 |
| Tax For Earlier Years | -0.02 | 0.01 | 0.02 | 0.00 | 0.00 |
| Total Tax Expenses | 3.71 | 3.14 | 1.95 | 1.04 | 0.37 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 11.50 | 9.82 | 6.69 | 2.73 | 0.87 |
| | | | | | |
| Profit/Loss From Continuing Operations | 11.50 | 9.82 | 6.69 | 2.73 | 0.87 |
| | | | | | |
| Profit/Loss For The Period | 11.50 | 9.82 | 6.69 | 2.73 | 0.87 |
| | | | | | |
| Minority Interest | -0.20 | -0.33 | -0.58 | -0.01 | 0.07 |
| Consolidated Profit/Loss After MI And Associates | 11.30 | 9.49 | 6.11 | 2.72 | 0.93 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 8.12 | 18.67 | 60.07 | 26.80 | 9.19 |
| Diluted EPS (Rs.) | 8.12 | 18.67 | 60.07 | 26.80 | 9.19 |
